Health Condition 1: H259- Unspecified age-related cataract
Conditions
Interventions
Intervention1: Sodium Hyaluronate Ophthalmic Solution (Hyloject): Sodium Hyaluronate Ophthalmic Solution (Hylojet) is a prefilled, cohesive viscoelastic agent administered intraoperatively into the an
Sponsors
Datta Meghe Institute of Higher Education and Research
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients with senile cataract and diagnosed diabetes mellitus. 2.Patients willing to give informed consent
Exclusion criteria
Exclusion criteria: 1.Preoperative glaucoma or IOP more than 20 mmHg. 2.Intraoperative complications like manual dilatation of pupil, posterior capsular rent, sulcus IOL placement. 3.Presence of subluxation, pseudoexfoliation, or other associated ocular/corneal pathology. 4.Previous intraocular surgery in study eye.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative corneal endothelial cell loss associated with different viscoelastic agentsTimepoint: Pre-Operative, Post-Operative Day 1, Day 15, and 1 Month | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual Acuity (Both Uncorrected and Corrected Visual Acuity)Timepoint: Pre-Operative, Post-Operative Day 1, Day 15, and 1 Month;Intraocular Pressure (IOP) ChangesTimepoint: Pre-Operative, Post-Operative Day 1, Day 15, and 1 Month;Postoperative Complications Related To Viscoelastic AgentsTimepoint: Post-Operative Day 1, Day 15, and 1 Month | — |
Countries
India
Contacts
Public ContactDr Sachin Daigavane
Datta Meghe Institute of Higher Education & Research
Outcome results
None listed